4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001193125-26-403355
Director, President and CEO bought 12,500 shares at $20.23 ($252,875)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jarrett Jennifer Director, President and CEO | 2026-09-25 | Purchase | +12,500 | $20.23 | $252,875 | 512,500 | D |
| Open-market purchases · 12,500 sh · avg $20.23 · $252,875 | |||||||
Loading xslF345X06/ownership.xml…